Antiretroviral Treatment of HIV/AIDS During Pregnancy

This Insights in the Women’s Health series describes the availability, timing, and risks of antiretroviral therapy (ART) in pregnant individuals who have HIV infection.

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	JAMA : the journal of the American Medical Association 2023-04, Vol.329 (15), p.1308-1309
Hauptverfasser:	Eke, Ahizechukwu C, Lockman, Shahin, Mofenson, Lynne M
Format:	Artikel
Sprache:	eng
Schlagworte:	Acquired immune deficiency syndrome Acquired Immunodeficiency Syndrome - drug therapy AIDS Anti-HIV Agents - therapeutic use Anti-Retroviral Agents - therapeutic use Antiretroviral agents Antiretroviral therapy Breast feeding Disease transmission Female Health risks HIV HIV Infections - drug therapy Human immunodeficiency virus Humans Infectious Disease Transmission, Vertical - prevention & control Pregnancy Pregnancy Complications, Infectious - drug therapy Public health Sexually transmitted diseases STD
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	This Insights in the Women’s Health series describes the availability, timing, and risks of antiretroviral therapy (ART) in pregnant individuals who have HIV infection.
ISSN:	0098-7484 1538-3598
DOI:	10.1001/jama.2023.5076